Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
This build-up can lead to severe megaloblastic anemia and some other health conditions
METAOD005: A Phase IIb (randomized, double-blind, placebo-controlled) study to assess the efficacy (reduction in body weight), safety and tolerability of 12 weeks treatment with daily doses (1, 5, 10, 20 or 30 mg AOD9604) administered orally (capsules) in 300 healthy, clinically obese males, and females of non-child bearing potential, with a BMI 35 kg/m 2
What Are the CPT Code 96372 Rules To Ensure Successful Reimbursement
Healthy red blood cell formation
US$ 26.44
US$ 21.66
US$ 26.97
US$ 25.04
US$ 22.09
US$ 25.02
US$ 27.64
